Diagnosis and treatment of pulmonary arterial hypertension: a review
NF Ruopp, BA Cockrill - Jama, 2022 - jamanetwork.com
Importance Pulmonary arterial hypertension (PAH) is a subtype of pulmonary hypertension
(PH), characterized by pulmonary arterial remodeling. The prevalence of PAH is …
(PH), characterized by pulmonary arterial remodeling. The prevalence of PAH is …
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary …
M Humbert, G Kovacs, MM Hoeper… - European heart …, 2022 - academic.oup.com
Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …
clinical conditions and may be associated with a variety of cardiovascular and respiratory …
[HTML][HTML] COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension
MM Hoeper, C Pausch, KM Olsson… - European …, 2022 - Eur Respiratory Soc
Background Risk stratification plays an essential role in the management of patients with
pulmonary arterial hypertension (PAH). The current European guidelines propose a three …
pulmonary arterial hypertension (PAH). The current European guidelines propose a three …
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
M Humbert, G Kovacs, MM Hoeper… - European …, 2023 - Eur Respiratory Soc
Guidelines summarize and evaluate available evidence, with the aim of assisting health
professionals in proposing the best management strategies for an individual patient with a …
professionals in proposing the best management strategies for an individual patient with a …
[HTML][HTML] Temporal trends in pulmonary arterial hypertension: results from the COMPERA registry
MM Hoeper, C Pausch, E Grünig… - European …, 2022 - Eur Respiratory Soc
Background Since 2015, the European pulmonary hypertension guidelines recommend the
use of combination therapy in most patients with pulmonary arterial hypertension (PAH) …
use of combination therapy in most patients with pulmonary arterial hypertension (PAH) …
Mortality in pulmonary arterial hypertension in the modern era: early insights from the pulmonary hypertension association registry
Background Current mortality data for pulmonary arterial hypertension (PAH) in the United
States are based on registries that enrolled patients prior to 2010. We sought to determine …
States are based on registries that enrolled patients prior to 2010. We sought to determine …
Pathophysiology and pathogenic mechanisms of pulmonary hypertension: role of membrane receptors, ion channels, and Ca2+ signaling
A Balistrieri, A Makino, JXJ Yuan - Physiological Reviews, 2023 - journals.physiology.org
The pulmonary circulation is a low-resistance, low-pressure, and high-compliance system
that allows the lungs to receive the entire cardiac output. Pulmonary arterial pressure is a …
that allows the lungs to receive the entire cardiac output. Pulmonary arterial pressure is a …
Aggressive afterload lowering to improve the right ventricle: a new target for medical therapy in pulmonary arterial hypertension?
CD Vizza, IM Lang, R Badagliacca… - American journal of …, 2022 - atsjournals.org
Despite numerous therapeutic advances in pulmonary arterial hypertension, patients
continue to suffer high morbidity and mortality, particularly considering a median age of 50 …
continue to suffer high morbidity and mortality, particularly considering a median age of 50 …
Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies
H Christou, RA Khalil - American Journal of Physiology …, 2022 - journals.physiology.org
Pulmonary hypertension (PH) is a serious disease characterized by various degrees of
pulmonary vasoconstriction and progressive fibroproliferative remodeling and inflammation …
pulmonary vasoconstriction and progressive fibroproliferative remodeling and inflammation …
[HTML][HTML] Mortality trends in pulmonary arterial hypertension in Canada: a temporal analysis of survival per ESC/ERS guideline era
JGE Zelt, J Sugarman, J Weatherald… - European …, 2022 - Eur Respiratory Soc
Background The evolution in pulmonary arterial hypertension (PAH) management has been
summarised in three iterations of the European Society of Cardiology/European Respiratory …
summarised in three iterations of the European Society of Cardiology/European Respiratory …